DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» IDH1
IDH1
Ovulation-Selective Genes: the Generation and Characterization of an Ovulatory-Selective Cdna Library
Download
Isocitrate Dehydrogenase 1 (NADP+) (I5036)
NRF2 and the Ambiguous Consequences of Its Activation During Initiation and the Subsequent Stages of Tumourigenesis
Energy Metabolism in IDH1 Wild-Type and IDH1-Mutated Glioblastoma Stem Cells: a Novel Target for Therapy?
Methylation-Dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1 Mutant Gliomas
Computational Inferences of Mutations Driving Mesenchymal Differentiation in Glioblastoma
Wild-Type and Mutated IDH1/2 Enzymes and Therapy Responses
BCAT1 Expression Associates with Ovarian Cancer Progression: Possible Implications in Altered Disease Metabolism
(IDH1) Helps Regulate Catalysis and Ph Sensitivity
Integrated Analysis of Cancer Stem Cells-Associated Lncrna-Mirna-Mrna Network for Ovarian Cancer Via Microarray and Gene Expression Omnibus Database
Molecular and Functional Analyses of Mutant Idh1 in Murine Neural Stem and Progenitor Cells
Functional and Topographic Effects on DNA Methylation in IDH1/2 Mutant
Isocitrate Dehydrogenase Status and Molecular Subclasses of Glioma and Glioblastoma
Exploiting Metabolic Vulnerabilities for Personalized Therapy in Acute Myeloid Leukemia Lucille Stuani, Marie Sabatier, Jean-Emmanuel Sarry
Metabolic Network-Based Stratification of Hepatocellular Carcinoma Reveals Three Distinct Tumor Subtypes
IDH1 and IDH2 Mutations
IDH1 Abbott Realtime PCR Diagnostic Test
Top View
Identification of a Small Molecule Inhibitor of 3-Phosphoglycerate Dehydrogenase to Target Serine Biosynthesis in Cancers,” by Edouard Mullarky, Natasha C
Gene Expression Changes in Subcutaneous Adipose Tissue Due to Cushing’S Disease
Molecular Pathways: Isocitrate Dehydrogenase Mutations in Cancer Owen Clark1, Katharine Yen2, and Ingo K
IDH1 Targeting As a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives
Synergistic Activity of IDH1 Inhibitor BAY1436032 with Azacitidine in IDH1 Mutant Acute Myeloid Leukemia
The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes
Bioinformatic Analysis of Differentially Expressed Genes As Prognostic Markers in Pheochromocytoma and Paraganglioma Tumors
Gene of the Month: IDH1 J Clin Pathol: First Published As 10.1136/Jclinpath-2020-206813 on 29 July 2020
The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives
IDH1 Non-Canonical Mutations and Survival in Patients with Glioma
IDH1 Mutation of Gliomas with Long-Term Survival Analysis
A Drug Screening Pipeline Using 2D and 3D Patient-Derived in Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma
Supplementary Figure S1. Immunofluorescence of Canine Primary Breast Tumor
Leukemia Stemness and Co-Occurring Mutations Drive Resistance to IDH Inhibitors in Acute Myeloid Leukemia
Cholesterol Lowering: Role in Cancer Prevention and Treatment
Chapter 9: the Therapy-Sensitizing Effects of IDH1 and IDH2 Mutations in Cancer
IDH1 Deficiency Attenuates Gluconeogenesis in Mouse Liver by Impairing Amino Acid Utilization
TIBSOVO (Ivosidenib) RATIONALE for INCLUSION in PA PROGRAM